title: Companies face ethical issues over Tamiflu.
authors.forename: Cris
authors.initials: C
authors.lastname: Prystay
authors.forename: Murray
authors.initials: M
authors.lastname: Hiebert
authors.forename: Kate
authors.initials: K
authors.lastname: Linebaugh
mesh_terms: D000081:Acetamides; D000998:Antiviral Agents / Q000600:supply & distribution* / Q000627:therapeutic use; D001208:Asia; D004189:Disaster Planning; D004196:Disease Outbreaks / Q000517:prevention & control; D004356:Drug Storage; D006801:Humans; D007221:Industry / Q000941:ethics*; D053124:Influenza A Virus, H5N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy*; D053139:Oseltamivir; D012941:Social Responsibility
chemical_list: D000081:Acetamides; D000998:Antiviral Agents; D053139:Oseltamivir